Compositions and methods using IL-8 to improve milk production and reproductive health in mammals

US10500253B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10500253-B2
Application numberUS-201615541126-A
CountryUS
Kind codeB2
Filing dateJan 5, 2016
Priority dateJan 5, 2015
Publication dateDec 10, 2019
Grant dateDec 10, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides compositions and methods for improving reproductive health of mammals and increasing milk production from female mammals. The methods involve administering an effective amount of IL-8 to a female mammal such that the reproductive health of the mammal is improved, or milk production from the mammal is increased, or the fat content of the milk is increased. In another aspect the disclosure includes prophylaxis and/or therapy of uterine conditions by administering IL-8 to a female mammal.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for inhibiting the development of puerperal metritis in a non-human female mammal comprising administering to the female mammal an effective amount of Interleukin-8 (IL-8), wherein the female mammal is within twenty weeks post parturition when the IL-8 is administered. 2. The method of claim 1 , wherein the administration of the IL-8 is an intrauterine administration or an intravaginal administration. 3. The method of claim 1 , wherein the female mammal is a member of a population of female mammals of the same species, the method further comprising administering the IL-8 to other members of the population within twenty weeks post parturition, such that inhibition of the development of puerperal metritis occurs in the other members subsequent to the administration. 4. The method of claim 1 , wherein the mammal is a bovine mammal. 5. The method of claim 4 , wherein the bovine mammal is a dairy cow.

Assignees

Inventors

Classifications

  • for lactation disorders, e.g. galactorrhoea · CPC title

  • Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00) · CPC title

  • Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

  • Polymeric derivatives, e.g. peptides or proteins · CPC title

  • IL-8 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10500253B2 cover?
The present disclosure provides compositions and methods for improving reproductive health of mammals and increasing milk production from female mammals. The methods involve administering an effective amount of IL-8 to a female mammal such that the reproductive health of the mammal is improved, or milk production from the mammal is increased, or the fat content of the milk is increased. In anot…
Who is the assignee on this patent?
Univ Cornell
What technology area does this patent fall under?
Primary CPC classification A61K38/2053. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).